The Diagnostic Significance of PDGF, EphA7, CCR5, and CCL5 Levels in Colorectal Cancer

被引:26
|
作者
Ucuncu, Muhammed [1 ]
Serilmez, Murat [2 ]
Sari, Murat [3 ]
Bademler, Suleyman [4 ]
Karabulut, Senem [3 ]
机构
[1] Istanbul Gelisim Univ, Hlth Sci Inst, TR-34310 Istanbul, Turkey
[2] Istanbul Univ, Inst Oncol, Dept Basic Oncol, TR-34093 Istanbul, Turkey
[3] Istanbul Univ, Inst Oncol, Dept Med Oncol, TR-34093 Istanbul, Turkey
[4] Istanbul Univ, Inst Oncol, Dept Surg, TR-34093 Istanbul, Turkey
关键词
CCL5; CCR5; chemokine; colorectal carcinoma; cytokine; EphA7; PDGF; CELLS; EXPRESSION; MICROENVIRONMENT; FIBROBLASTS; PREVENTION; GROWTH;
D O I
10.3390/biom9090464
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
In this study, we compared the levels of C-C chemokine receptor type 5 (CCR5), C-C motif chemokine ligand 5 (CCL5), platelet-derived growth factor (PDGF), and EphrinA7 (EphA7) in patients with colorectal carcinoma and healthy controls in order to investigate the significance and usability of these potential biomarkers in early diagnosis of colorectal cancer. The study included 70 colorectal carcinoma patients and 40 healthy individuals. The CCR5, CCL5, PDGF, and EphA7 levels were measured using ELISA in blood samples. PDGF-BB, EphA7, CCR5, and CCL5 levels of the patients with colorectal carcinoma were significantly higher compared to the control group (p < 0.001 for each comparison). Our logistic regression analysis (the area under the curve was 0.958) supports the notion that PDGF-BB, EphA7, and CCL5 are potential biomarkers for the diagnosis of colon cancer. The sensitivity, specificity, and positive and negative predictive values were found to be 87.9%, 87.5%, 92.1%, and 81.4%, respectively. To our knowledge, this is the first study that investigates the relationship between colorectal carcinoma and the four biomarkers CCL5, CCR5, PDGF, and EphA7. The significantly elevated levels of all these parameters in the patient group compared to the healthy controls indicate that they can be used for the early diagnosis of colorectal carcinoma.
引用
收藏
页数:9
相关论文
共 50 条
  • [1] The Role of Biomarkers in the Early Diagnosis of Gastric Cancer: A Study on CCR5, CCL5, PDGF, and EphA7
    Bademler, Sueleyman
    Kilic, Berkay
    Ucuncu, Muhammed
    Zirtiloglu, Alisan
    Ilhan, Burak
    CURRENT ISSUES IN MOLECULAR BIOLOGY, 2024, 46 (09) : 10651 - 10661
  • [2] CCR5 and CCL5 in metastatic colorectal cancer
    Schlechter, Benjamin L.
    Stebbing, Justin
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2024, 12 (05)
  • [3] Biological significance of CCR5/CCL5 axis in liver cancer
    Singh, R.
    Singh, S.
    Mishra, M.
    Lillard, J., Jr.
    EUROPEAN JOURNAL OF IMMUNOLOGY, 2019, 49 : 148 - 148
  • [4] The CCL5/CCR5 Axis in Cancer Progression
    Aldinucci, Donatella
    Borghese, Cinzia
    Casagrande, Naike
    CANCERS, 2020, 12 (07) : 1 - 30
  • [5] Expression of CCL5 (RANTES) and CCR5 in prostate cancer
    Vaday, GG
    Peehl, DM
    Kadam, PA
    Lawrence, DM
    PROSTATE, 2006, 66 (02): : 124 - 134
  • [6] The potential to target CCL5/CCR5 in breast cancer
    Velasco-Velazquez, Marco
    Xolalpa, Wendy
    Pestell, Richard G.
    EXPERT OPINION ON THERAPEUTIC TARGETS, 2014, 18 (11) : 1265 - 1275
  • [7] CCR5 and CCL5 gene expression in colorectal cancer: comprehensive profiling and clinical value
    Battaglin, Francesca
    Baca, Yasmine
    Millstein, Joshua
    Yang, Yan
    Xiu, Joanne
    Arai, Hiroyuki
    Wang, Jingyuan
    Ou, Fang-Shu
    Innocenti, Federico
    Mumenthaler, Shannon M.
    Jayachandran, Priya
    Kawanishi, Natsuko
    Lenz, Annika
    Soni, Shivani
    Algaze, Sandra
    Zhang, Wu
    Khoukaz, Taline
    Roussos Torres, Evanthia
    Seeber, Andreas
    Abraham, Jim P.
    Lou, Emil
    Philip, Philip A.
    Weinberg, Benjamin A.
    Shields, Anthony F.
    Goldberg, Richard M.
    Marshall, John L.
    Venook, Alan P.
    Korn, W. Michael
    Lenz, Heinz-Josef
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2024, 12 (01)
  • [8] Biological and Clinical Significance of the CCR5/CCL5 Axis in Hepatocellular Carcinoma
    Singh, Santosh K.
    Mishra, Manoj K.
    Rivers, Brian M.
    Gordetsky, Jennifer B.
    Bae, Sejong
    Singh, Rajesh
    CANCERS, 2020, 12 (04)
  • [9] Expression of CCR5 and its ligand CCL5 in pancreatic cancer
    Singh, Santosh Kumar
    Banerjee, Saswati
    Lillard, James W., Jr.
    Singh, Rajesh
    JOURNAL OF IMMUNOLOGY, 2016, 196
  • [10] The CCL5/CCR5 axis in ulcerative colitis
    Qu, Fan Fan
    Wu, Ya Qian
    Bin Ji, Jian
    Yan, Lin
    Wei, Jing Jing
    Song, Qing Chao
    Xu, Bao Qing
    Cheng, Ming
    Zhou, Zheng Hua
    CELLULAR IMMUNOLOGY, 2025, 407